NVAX News and Press, Novavax Inc.

2024-07-03 06:55:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips During May and June, Novavax (NASDAQ: NVAX ) shares appeared to be making a major comeback. At the time, news of a partnership deal with pharma firm Sanofi (NASDAQ: SNY ...

2024-07-02 11:49:49 ET More on Moderna, Pfizer, etc. Pfizer: It Could Be A Bargain Moderna: Really Strong Competition Novavax seeks FDA authorization for updated JN.1 COVID shot Wall Street Lunch: Pfizer Looks To Take Next Step In Weight-Loss Drugs ...

Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...

2024-06-27 14:21:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks to buy now reflect a more dynamic shift in investor focus of late. Over the past few years, the biotech space attracted plenty of investor interest, driven by the Covid-19 ...

2024-06-26 10:47:03 ET Novavax, Inc. (NVAX) NVAX is trading DOWN for the last 4 days, and it at trading at $13.72 with volume of 2,036,792 and a one day change of $-0.28 (-2.00%). Novavax, Inc. has a 52-week low of 3.53 and a 52-week high of $23.86. The business's 50-day moving aver...

2024-06-24 12:41:43 ET More on Novavax Novavax: New Chapter, Questions Remain Novavax: Bird Flu And COVID-19 Headlines Trigger Rally Novavax, Inc. (NVAX) Jefferies 2024 Global Healthcare Conference (Transcript) Novavax seeks FDA authorization for updated JN.1...

Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine PR Newswire Novavax's JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3 GAITHERSBURG, Md. , Ju...

2024-06-20 15:02:43 ET Summary Novavax, Inc. secured a lucrative deal with Sanofi, receiving potentially $1.2 billion in cash and future royalties for Covid vaccines. The deal significantly improved Novavax's financial position, but the stock has already rallied from $4 to $14, li...

2024-06-18 10:29:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It was not long ago that Novavax (NASDAQ: NVAX ) was among the stocks with high short interest. The stock had been trending lower for an extended period. However, with one posit...

2024-06-17 09:06:25 ET Summary Novavax has seen a surge in stock price due to recent COVID-19 and bird flu vaccine developments, reaching over $27 per share. The company is making headlines with updates on their COVID-19 vaccine, bird flu vaccine, and potential FDA approval, with ...